Figure 3: Urinary TBARs excretion (A) and MCP-1 excretion (B) in streptozotocin-induced diabetic mice. Both urinary TBARs and MCP-1 excretion levels were significantly elevated in diabetic versus control mice (*P<0.05 vs. control mice). Only baicalein treatment for 10 weeks significantly reduced TBARs excretion in diabetic mice (#P<0.05 vs. diabetic mice, n=6-8/ group).